The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

Article Abstract:

Parathyroid hormone and alendronate together are not more effective for treating osteoporosis than either one alone, according to a study of 238 postmenopausal women. Parathyroid hormone stimulates bone growth and alendronate prevents bone destruction. So researchers believed the two treatments would be better than either one alone. Further research will be necessary to determine whether this is true.

Evaluation

---

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

Article Abstract:

An attempt is made to question whether antiresorptive therapy is required to maintain gains in bone mineral density after one year of therapy with parathyroid hormone. It is concluded that after one year of parathyroid hormone (1-84), densitometric gains appear to be maintained or increased with alendronate but lost if an antiresorptive agent does not follow parathyroid hormone.

Science & research, New England States, Health aspects, Research, Women, Hormone therapy, Women's health, New England

---

Similar abstracts:

• Abstracts: Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer
• Abstracts: The emergency department as a pathway to admission for poor and high-cost patients. Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources
• Abstracts: Biology and management of bladder cancer. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.